Androgen receptor inhibitor plus chemotherapy and ADT in a patient with mHSPC and multiple comorbidities
22 Apr 2024
byDr. Darren Poon
Specialist in Clinical Oncology
Hong Kong Sanatorium & Hospital
Hong Kong
A 66-year-old male nonsmoker and nondrinker complained of generalized bone pain, poor appetite and abdominal discomfort in December 2022. He had hypertension, which was controlled with amlodipine/valsartan 5 mg/80 mg, and sleep apnoea. He was also a hepatitis B virus (HBV) carrier on maintenance entecavir. He had no family history of prostate cancer.
